Globus Medical, Inc.
NYSEGlobus Medical reports Q1 2026 results on May 7 with short sellers quietly adding pressure and options markets turning more defensive than their recent norm. The most notable shift in positioning is the steady climb in short interest. It has risen nearly 10% over the past month to 3.2% of the free float — not an extreme level in absolute terms, but the direction is clear, with…
Snapshot as of 9 May 2026
Globus Medical reports Q1 2026 results on May 7 with short sellers quietly adding pressure and options markets turning more defensive than their recent norm. The most notable shift in positioning is the steady climb in…
GMED heads into its May 5 Q1 2026 earnings report with options traders unusually bullish and the analyst community firmly in the company's corner — a setup that leaves little room for disappointment. The clearest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GMED — free to start on ORTEX.
Sign up for free →Open GMED on ORTEX